Danish drug maker Novo Nordisk says it has lowered its long-term guidance for 2016 due to a difficult U.S. market, sparking a nearly 14 percent drop in share prices in … Click to Continue »
Business News | KansasCity.com &, Kansas City Star: Business
Fri, 10/28/2016 - 1:28am
Danish drug maker Novo Nordisk says it has lowered its long-term guidance for 2016 due to a difficult U.S. market, sparking a nearly 14 percent drop in share prices in … Click to Continue »